4d Molecular Therapeutics
Clinical trials sponsored by 4d Molecular Therapeutics, explained in plain language.
-
Inhaled gene therapy aims to tackle cystic fibrosis lung damage
Disease control Recruiting nowThis study tests a new gene therapy called 4D-710 for adults with cystic fibrosis (CF) who cannot take or have stopped standard CF medications. The therapy is given as a single inhaled dose and aims to deliver a working gene to lung cells to help clear mucus and improve breathing…
Phase: PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
One shot could replace dozens: gene therapy trial for blinding eye disease
Disease control Recruiting nowThis phase 3 trial tests a single injection of 4D-150 gene therapy in 480 adults with wet age-related macular degeneration (nAMD). The goal is to see if one treatment can control the disease and reduce the need for frequent anti-VEGF eye injections. Participants receive either 4D…
Phase: PHASE3 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Gene therapy could cut eye injections for wet AMD patients
Disease control Recruiting nowThis study tests a gene therapy called 4D-150 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if a single injection into the eye can reduce the need for regular anti-VEGF injections. About 215 adults aged 50 and older…
Phase: PHASE1, PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:19 UTC